{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:05:52Z","timestamp":1786982752472,"version":"build-2736575974"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T00:00:00Z","timestamp":1547078400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s40261-018-00745-6","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T03:06:39Z","timestamp":1547089599000},"page":"241-252","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Clinical Characteristics of Japanese Patients with Palmoplantar Pustulosis"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8390-2573","authenticated-orcid":false,"given":"Toshiyuki","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,10]]},"reference":[{"key":"745_CR1","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1001\/archderm.1935.01470060002001","volume":"32","author":"GC Andrews","year":"1935","unstructured":"Andrews GC, Machacek GF. Pustular bacterids of the hands and feet. Arch Dermatol Syphilol. 1935;32:837\u201347.","journal-title":"Arch Dermatol Syphilol"},{"key":"745_CR2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3109\/09546631003636817","volume":"22","author":"AC Waal de","year":"2011","unstructured":"de Waal AC, van de Kerkhof PC. Pustulosis palmoplantaris is a disease distinct from psoriasis. J Dermatolog Treat. 2011;22:102\u20135.","journal-title":"J Dermatolog Treat"},{"key":"745_CR3","doi-asserted-by":"publisher","first-page":"e335","DOI":"10.1111\/jdv.14131","volume":"31","author":"AMG Brunasso","year":"2017","unstructured":"Brunasso AMG, Massone C. Psoriasis and palmoplantar pustulosis: an endless debate? J Eur Acad Dermatol Venereol. 2017;31:e335\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"745_CR4","doi-asserted-by":"publisher","first-page":"e342","DOI":"10.1111\/jdv.14136","volume":"31","author":"M Misiak-Galazka","year":"2017","unstructured":"Misiak-Galazka M, Wolska H, Rudnicka L. Is palmoplantar pustulosis simply a variant of psoriasis or a distinct entity? J Eur Acad Dermatol Venereol. 2017;31:e342\u20133.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"745_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/jdv.13846","volume":"31","author":"M Misiak-Galazka","year":"2017","unstructured":"Misiak-Galazka M, Wolska H, Rudnicka L. What do we know about palmoplantar pustulosis? J Eur Acad Dermatol Venereol. 2017;31:38\u201344.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"745_CR6","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1111\/j.1468-3083.2009.03296.x","volume":"23","author":"T Yamamoto","year":"2009","unstructured":"Yamamoto T. Extra-palmoplantar lesions associated with palmoplantar pustulosis. J Eur Acad Dermatol Venereol. 2009;23:1227\u201332.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"745_CR7","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/j.1468-3083.2010.03648.x","volume":"24","author":"AMG Brunasso","year":"2010","unstructured":"Brunasso AMG, Massone C. Can we really separate palmoplantar pustulosis from psoriasis? J Eur Acad Dermatol Venereol. 2010;24:619\u201321.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"745_CR8","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/j.1468-3083.2010.03649.x","volume":"24","author":"T Yamamoto","year":"2010","unstructured":"Yamamoto T. Can we really separate palmoplantar pustulosis from psoriasis? Reply. J Eur Acad Dermatol Venereol. 2010;24:621.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"745_CR9","doi-asserted-by":"publisher","first-page":"e006450","DOI":"10.1136\/bmjopen-2014-006450","volume":"5","author":"K Kubota","year":"2015","unstructured":"Kubota K, Kamijima Y, Sato T, et al. Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database. BMJ Open. 2015;5:e006450.","journal-title":"BMJ Open"},{"key":"745_CR10","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/j.1346-8138.1995.tb03948.x","volume":"22","author":"T Akiyama","year":"1995","unstructured":"Akiyama T, Seishima M, Watanabe H, et al. The relationship of onset and exacerbation of pustulosis palmaris et plantaris to smoking and focal infections. J Dermatol. 1995;22:930\u20134.","journal-title":"J Dermatol"},{"key":"745_CR11","first-page":"1775","volume":"125","author":"K Fujishiro","year":"2015","unstructured":"Fujishiro K, Tsuboi R, Okubo Y. A statistical analysis of 111 cases of pustulosis palmaris et plantaris during the past 3\u00a0years [in Japanese]. Jpn J Dermatol. 2015;125:1775\u201382.","journal-title":"Jpn J Dermatol"},{"key":"745_CR12","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1111\/ijd.14023","volume":"57","author":"T Hiraiwa","year":"2018","unstructured":"Hiraiwa T, Yamamoto T. Comorbidities of Japanese patients with palmoplantar pustulosis: a report from a single center. Int J Dermatol. 2018;57:e40\u20131.","journal-title":"Int J Dermatol"},{"key":"745_CR13","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1136\/bmj.291.6499.861","volume":"291","author":"CJ O\u2019Doherty","year":"1985","unstructured":"O\u2019Doherty CJ, MacIntyre C. Palmoplantar pustulosis and smoking. Br Med J. 1985;291:861\u20134.","journal-title":"Br Med J"},{"key":"745_CR14","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/000155502320624069","volume":"82","author":"E Hagforsen","year":"2002","unstructured":"Hagforsen E, Awder M, Lefvert A-K, et al. Palmoplantar pustulosis: an autoimmune disease precipitated by smoking? Acta Derm Venereol. 2002;82:341\u20136.","journal-title":"Acta Derm Venereol"},{"key":"745_CR15","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1046\/j.1468-3083.2003.00510.x","volume":"17","author":"R Gim\u00e9nez-Garcia","year":"2003","unstructured":"Gim\u00e9nez-Garcia R, S\u00e1nchez-Ram\u00f3n S, Cuellar-Olmedo LA. Palmoplantar pustulosis: a clinicoepidemiological study. The relationship between tobacco use and thyroid function. J Eur Acad Dermatol Venereol. 2003;17:276\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"745_CR16","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/j.1468-3083.2009.03282.x","volume":"23","author":"HA Miot","year":"2009","unstructured":"Miot HA, Miot LD, Lopes PS, et al. Association between palmoplantar pustulosis and cigarette smoking in Brazil: a case-control study. J Eur Acad Dermatol Venereol. 2009;23:1173\u20137.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"745_CR17","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jaad.2005.07.024","volume":"54","author":"G Micha\u00eblsson","year":"2006","unstructured":"Micha\u00eblsson G, Gustafsson K, Hagforsen E. The psoriasis variant palmoplantar pustulosis can be improved after cessation of smoking. J Am Acad Dermatol. 2006;54:737\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"745_CR18","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1001\/archderm.1974.01630040028005","volume":"109","author":"M Uehara","year":"1974","unstructured":"Uehara M, Ofuji S. The morphogenesis of pustulosis palmaris et plantaris. Arch Dermatol. 1974;109:518\u201320.","journal-title":"Arch Dermatol"},{"key":"745_CR19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1159\/000247423","volume":"185","author":"PHG Krieg","year":"1992","unstructured":"Krieg PHG, Bacharach-Buhles M, el-Gammal S, Altmeyer P. The pustule in palmoplantar psoriasis: transformed vesicle or mature microabscess? Dermatology. 1992;185:104\u201312.","journal-title":"Dermatology"},{"key":"745_CR20","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.clindermatol.2016.09.004","volume":"35","author":"B Engin","year":"2017","unstructured":"Engin B, A\u015fkin \u00d6, T\u00fcz\u00fcn Y. Palmoplantar psoriasis. Clin Dermatol. 2017;35:19\u201327.","journal-title":"Clin Dermatol"},{"key":"745_CR21","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1365-2133.1996.tb07946.x","volume":"134","author":"AD Burden","year":"1996","unstructured":"Burden AD, Kemmett D. The spectrum of nail involvement in palmoplantar pustulosis. Br J Dermatol. 1996;134:1079\u201382.","journal-title":"Br J Dermatol"},{"key":"745_CR22","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1111\/ijd.13224","volume":"56","author":"T Hiraiwa","year":"2017","unstructured":"Hiraiwa T, Yamamoto T. Nail involvement associated with palmoplantar pustulosis. Int J Dermatol. 2017;56:e28\u20139.","journal-title":"Int J Dermatol"},{"issue":"Suppl 1","key":"745_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000316169","volume":"221","author":"R Baran","year":"2010","unstructured":"Baran R. The burden of nail psoriasis: an introduction. Dermatology. 2010;221(Suppl 1):1\u20135.","journal-title":"Dermatology"},{"key":"745_CR24","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1111\/jdv.12545","volume":"29","author":"G Becher","year":"2015","unstructured":"Becher G, Jamieson L, Leman J. Palmoplantar pustulosis-a retrospective review of comorbid conditions. J Eur Acad Dermatol Venereol. 2015;29:1854\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"745_CR25","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/1346-8138.12272","volume":"40","author":"T Yamamoto","year":"2013","unstructured":"Yamamoto T. Pustulotic arthro-osteitis associated with palmoplantar pustulosis. J Dermatol. 2013;40:857\u201363.","journal-title":"J Dermatol"},{"key":"745_CR26","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/S0190-9622(94)70233-0","volume":"31","author":"H Torii","year":"1994","unstructured":"Torii H, Nakagawa H, Ishibashi Y. Osteoarthritis in 84 Japanese patients with palmoplantar pustulosis. J Am Acad Dermatol. 1994;31:732\u20135.","journal-title":"J Am Acad Dermatol"},{"key":"745_CR27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1346-8138.1977.tb01011.x","volume":"4","author":"A Ishibashi","year":"1977","unstructured":"Ishibashi A, Nishiyama Y, Endo M, et al. Orthopdic symptoms in pustular bacterid (pustulosis palmaris et plantaris): Tietze\u2019s syndrome and arthritis of manubriosternal joint due to focal infection. J Dermatol. 1977;4:53\u20139.","journal-title":"J Dermatol"},{"key":"745_CR28","doi-asserted-by":"publisher","first-page":"221","DOI":"10.4103\/0019-5154.177769","volume":"61","author":"T Ohashi","year":"2016","unstructured":"Ohashi T, Hiraiwa T, Yamamoto T. Low prevalence of anti-cyclic citrullinated peptide antibodies in Japanese patients with pustulotic arthro-osteitis. Indian J Dermatol. 2016;61:221\u20132.","journal-title":"Indian J Dermatol"},{"key":"745_CR29","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/j.1365-2133.2006.07725.x","volume":"156","author":"G Micha\u00eblsson","year":"2007","unstructured":"Micha\u00eblsson G, Kristj\u00e1nsson G, Lundin IP, Hagforsen E. Palmoplantar pustulosis and gluten sensitivity: a study of serum antibodies against gliadin and tissue transglutaminase, the duodenal mucosa and effects of gluten-free diet. Br J Dermatol. 2007;156:659\u201366.","journal-title":"Br J Dermatol"},{"key":"745_CR30","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/0190-9622(92)70130-8","volume":"26","author":"WR Heymann","year":"1992","unstructured":"Heymann WR. Cutaneous manifestations of thyroid disease. J Am Acad Dermatol. 1992;26:885\u2013902.","journal-title":"J Am Acad Dermatol"},{"key":"745_CR31","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1067\/mjd.2003.257","volume":"48","author":"J Ai","year":"2003","unstructured":"Ai J, Leonhardt JM, Heymann WR. Autoimmune thyroid diseases: etiology, pathogenesis, and dermatologic manifestations. J Am Acad Dermatol. 2003;48:641\u201359.","journal-title":"J Am Acad Dermatol"},{"key":"745_CR32","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1111\/j.1346-8138.2000.tb02163.x","volume":"27","author":"A Seno","year":"2000","unstructured":"Seno A, Arata J, Matsuura Y, Suemitsu I. Palmoplantar pustulosis with pustulotic arthroosteitis involving temporal osteomyelitis and meningitis. J Dermatol. 2000;27:269\u201372.","journal-title":"J Dermatol"},{"key":"745_CR33","doi-asserted-by":"publisher","first-page":"e242","DOI":"10.1111\/j.1365-4632.2012.05839.x","volume":"53","author":"T Hiraiwa","year":"2014","unstructured":"Hiraiwa T, Rokkaku Y, Yamamoto T. Palmoplantar pustulosis with arthro-osteitis triggered by recurrent appendeal abscess 5\u00a0years after appendectomy. Int J Dermatol. 2014;53:e242\u20133.","journal-title":"Int J Dermatol"},{"key":"745_CR34","doi-asserted-by":"publisher","first-page":"721","DOI":"10.2340\/00015555-1552","volume":"93","author":"N Kikuchi","year":"2013","unstructured":"Kikuchi N, Yamamoto T. Dental infection as a triggering factor in palmoplantar pustulosis. Acta Derm Venereol. 2013;93:721\u20132.","journal-title":"Acta Derm Venereol"},{"key":"745_CR35","first-page":"274","volume":"1","author":"M-F Tsan","year":"2004","unstructured":"Tsan M-F, Gao B. Heat shock protein and innate immunity. Cell Mol Immunol. 2004;1:274\u20139.","journal-title":"Cell Mol Immunol"},{"key":"745_CR36","first-page":"197","volume":"523","author":"S Izaki","year":"1996","unstructured":"Izaki S, Goto Y, Kaburagi Y, et al. Antibody production to heat shock proteins with Mr 65 kD (HDP65) in cutaneous inflammation: a possible relation to focal infection. Acta Otolaryngol (Suppl). 1996;523:197\u2013200.","journal-title":"Acta Otolaryngol (Suppl)"},{"key":"745_CR37","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/jid.2009.65","volume":"129","author":"EG Harper","year":"2009","unstructured":"Harper EG, Guo C, Rizzo H, et al. Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. J Invest Dermatol. 2009;129:2175\u201383.","journal-title":"J Invest Dermatol"},{"key":"745_CR38","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/archdermatol.2010.168","volume":"146","author":"JV Lillis","year":"2010","unstructured":"Lillis JV, Guo C-S, Lee JJ, Blauvelt A. Increased IL-23 expression in palmoplantar psoriasis and hyperkeratotic hand dermatitis. Arch Dermatol. 2010;146:918\u20139.","journal-title":"Arch Dermatol"},{"key":"745_CR39","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/j.1365-2133.2010.09819.x","volume":"163","author":"E Hagforsen","year":"2010","unstructured":"Hagforsen E, Hedstrand H, Nyberg F, Micha\u00eblsson G. Novel findings of Langerhans cells and interleukin-17 expression in relation to the acrosyringium and pustule in palmoplantar pustulosis. Br J Dermatol. 2010;163:572\u20139.","journal-title":"Br J Dermatol"},{"key":"745_CR40","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1111\/j.1600-0625.2011.01325.x","volume":"20","author":"M Murakami","year":"2011","unstructured":"Murakami M, Hagforsen E, Morhenn V, et al. Patients with palmoplantar pustulosis have increased IL-17 and IL-22 levels both in the lesion and serum. Exp Dermatol. 2011;20:845\u20137.","journal-title":"Exp Dermatol"},{"key":"745_CR41","first-page":"161","volume":"523","author":"A Kataura","year":"1996","unstructured":"Kataura A, Tsubota H. Clinical analyses of focus tonsil and related diseases in Japan. Acta Otolaryngol Suppl. 1996;523:161\u20134.","journal-title":"Acta Otolaryngol Suppl"},{"key":"745_CR42","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.clim.2005.01.009","volume":"116","author":"H Nozawa","year":"2005","unstructured":"Nozawa H, Kishibe K, Takahara M, Harabuchi Y. Expression of cutaneous lymphocyte-associated antigen (CLA) in tonsillar T-cells and its induction by in vitro stimulation with alpha-streptococci in patients with pustulosis palmaris et plantaris (PPP). Clin Immunol. 2005;116:42\u201353.","journal-title":"Clin Immunol"},{"key":"745_CR43","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1080\/00016489950181431","volume":"119","author":"H Murakata","year":"1999","unstructured":"Murakata H, Harabuchi Y, Kataura A. Increased interleukin-6, interferon-gamma and tumor necrosis factor-alpha production by tonsillar mononuclear cells stimulated with alpha-streptococci in patients with pustulosis palmaris et plantaris. Acta Otolaryngol. 1999;119:384\u201391.","journal-title":"Acta Otolaryngol"},{"key":"745_CR44","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1365-2249.2009.03945.x","volume":"157","author":"T Yoshizaki","year":"2009","unstructured":"Yoshizaki T, Bandoh N, Ueda S, et al. Up-regulation of CC chemokine receptor 6 on tonsillar T cells and its induction by in vitro stimulation with \u03b1-streptococci in patients with pustulosis palmaris et plantaris. Clin Exp Immunol. 2009;157:71\u201382.","journal-title":"Clin Exp Immunol"},{"key":"745_CR45","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jdermsci.2007.12.010","volume":"50","author":"H Sakiyama","year":"2008","unstructured":"Sakiyama H, Kobayashi S, Dianzani U, et al. Possible involvement of T cell co-stimulation in pustulosis palmaris et plantaris via the induction of inducible co-stimulator in chronic focal infections. J Dermatol Sci. 2008;50:197\u2013207.","journal-title":"J Dermatol Sci"},{"key":"745_CR46","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.jaut.2012.03.003","volume":"39","author":"NM Moutsopoulos","year":"2012","unstructured":"Moutsopoulos NM, Kling HM, Angelov N, et al. Porphyromonas gingivalis promotes Th17 inducing pathways in chronic periodontitis. J Autoimmun. 2012;39:294\u2013303.","journal-title":"J Autoimmun"},{"key":"745_CR47","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/j.1468-3083.2006.01905.x","volume":"21","author":"T Yamamoto","year":"2007","unstructured":"Yamamoto T, Yokozeki H, Tsuboi R. Koebner\u2019s phenomenon associated with palmoplantar pustulosis. J Eur Acad Dermatol Venereol. 2007;21:990\u20132.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"745_CR48","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1046\/j.1523-1747.2003.12094.x","volume":"120","author":"K Asumalahti","year":"2003","unstructured":"Asumalahti K, Ameen M, Suomela S, et al. Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis. J Invest Dermatol. 2003;120:627\u201332.","journal-title":"J Invest Dermatol"},{"key":"745_CR49","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/j.1365-2133.2006.07731.x","volume":"156","author":"K Kingo","year":"2007","unstructured":"Kingo K, M\u04e7ssner R, K\u00f5ks S, et al. Association analysis of IL19, IL20 and IL24 genes in palmoplantar pustulosis. Br J Dermatol. 2007;156:646\u201352.","journal-title":"Br J Dermatol"},{"key":"745_CR50","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/1346-8138.13551","volume":"44","author":"T Takahashi","year":"2017","unstructured":"Takahashi T, Fujimoto N, Kabuto M, et al. Mutation analysis of IL-36RN gene in Japanese patients with palmoplantar pustulosis. J Dermatol. 2017;44:80\u20133.","journal-title":"J Dermatol"},{"key":"745_CR51","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00403-015-1611-x","volume":"308","author":"T-S Wang","year":"2016","unstructured":"Wang T-S, Chiu H-Y, Hong J-B, et al. Correlation of IL36RN mutation with different clinical features of pustular psoriasis in Chinese patients. Arch Dermatol Res. 2016;308:55\u201363.","journal-title":"Arch Dermatol Res"},{"key":"745_CR52","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1067\/mjd.2000.104305","volume":"42","author":"K Nakamura","year":"2000","unstructured":"Nakamura K, Imakado S, Takizawa M, et al. Exacerbation of pustulosis palmaris et plantaris after topical application of metals accompanied by elevated levels of leukotriene B4 in pustules. J Am Acad Dermatol. 2000;42:1021\u20135.","journal-title":"J Am Acad Dermatol"},{"key":"745_CR53","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/S0140-6736(05)67384-9","volume":"366","author":"T Yanagi","year":"2005","unstructured":"Yanagi T, Shimizu T, Abe R, Shimizu H. Zinc dental fillings and palmoplantar pustulosis. Lancet. 2005;366:1050.","journal-title":"Lancet"},{"key":"745_CR54","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/1346-8138.13751","volume":"44","author":"M Kouno","year":"2017","unstructured":"Kouno M, Nishiyama A, Minabe M, et al. Retrospective analysis of the clinical response of palmoplantar pustulosis after dental infection control and dental metal removal. J Dermatol. 2017;44:695\u20138.","journal-title":"J Dermatol"},{"key":"745_CR55","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1365-2249.2006.03226.x","volume":"146","author":"JT Minang","year":"2006","unstructured":"Minang JT, Arestr\u00f6m I, Troye-Blomberg M, et al. Nickel, cobalt, chromium, paradium and gold induce a mixed Th1- and Th2-type cytokine response in vitro in subjects with contact allergy to the respective metals. Clin Exp Immunol. 2006;146:417\u201326.","journal-title":"Clin Exp Immunol"},{"key":"745_CR56","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1139\/cjpp-2014-0460","volume":"93","author":"T Kuroishi","year":"2015","unstructured":"Kuroishi T. Regulation of immunological and inflammatory functions by biotin. Can J Physiol Pharmacol. 2015;93:1091\u20136.","journal-title":"Can J Physiol Pharmacol"},{"key":"745_CR57","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.4049\/jimmunol.162.4.2347","volume":"162","author":"M Laan","year":"1999","unstructured":"Laan M, Cui ZH, Hoshino H, et al. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol. 1999;162:2347\u201352.","journal-title":"J Immunol"},{"key":"745_CR58","doi-asserted-by":"publisher","first-page":"e110677","DOI":"10.1371\/journal.pone.0110677","volume":"9","author":"M Murakami","year":"2014","unstructured":"Murakami M, Kaneko T, Nakatsuji T, et al. Vesicular LL-37 contributes to inflammation of the lesional skin of palmoplantar pustulosis. PLoS One. 2014;9:e110677.","journal-title":"PLoS One"},{"key":"745_CR59","doi-asserted-by":"publisher","first-page":"669","DOI":"10.4049\/jimmunol.181.1.669","volume":"181","author":"L Skov","year":"2008","unstructured":"Skov L, Beurskens FJ, Zachariae COC, et al. IL-8 as antibody therapeutic target in inflammatory diseases: reduction of clinical activity in palmoplantar pustulosis. J Immunol. 2008;181:669\u201379.","journal-title":"J Immunol"},{"key":"745_CR60","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1159\/000087019","volume":"211","author":"M Ozawa","year":"2005","unstructured":"Ozawa M, Terui T, Tagami H. Localization of IL-8 and complement components in lesional skin of psoriasis vulgaris and pustulosis palmaris et plantaris. Dermatology. 2005;211:249\u201355.","journal-title":"Dermatology"},{"key":"745_CR61","doi-asserted-by":"publisher","first-page":"7678","DOI":"10.4049\/jimmunol.175.11.7678","volume":"175","author":"M Keller","year":"2005","unstructured":"Keller M, Spanou Z, Schaerli P, et al. T cell-regulated neutrophilic inflammation in autoinflammatory diseases. J Immunol. 2005;175:7678\u201386.","journal-title":"J Immunol"},{"key":"745_CR62","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1046\/j.1365-2133.1998.02113.x","volume":"138","author":"MO Eriksson","year":"1998","unstructured":"Eriksson MO, Hagforsen Lundin IP, Micha\u00eblsson G. Palmoplantar pustulosis: a clinical and immunohistological study. Br J Dermatol. 1998;138:390\u20138.","journal-title":"Br J Dermatol"},{"key":"745_CR63","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1038\/jid.2010.87","volume":"130","author":"M Murakami","year":"2010","unstructured":"Murakami M, Ohtake T, Horibe Y, et al. Acrosyringium is the main site of the vesicle\/pustule formation in palmoplantar pustulosis. J Invest Dermatol. 2010;130:2010\u20136.","journal-title":"J Invest Dermatol"},{"key":"745_CR64","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1007\/s00403-010-1070-3","volume":"302","author":"E Hagforsen","year":"2010","unstructured":"Hagforsen E, Micha\u00eblsson G, Stridsberg M. Normal and PPP-affected palmoplantar sweat gland express neuroendocrine markers chromogranins and synaptophysin differently. Arch Dermatol Res. 2010;302:685\u201393.","journal-title":"Arch Dermatol Res"},{"key":"745_CR65","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1016\/j.lfs.2007.01.045","volume":"80","author":"E Hagforsen","year":"2007","unstructured":"Hagforsen E. The cutaneous non-neuronal cholinergic system and smoking related dermatoses: studies of the psoriasis variant palmoplantar pustulosis. Life Sci. 2007;80:2227\u201334.","journal-title":"Life Sci"},{"key":"745_CR66","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1046\/j.1365-2133.2002.04640.x","volume":"146","author":"E Hagforsen","year":"2002","unstructured":"Hagforsen E, Edvinsson M, Nordlind K, Micha\u00eblsson G. Expression of nicotinic receptors in the skin of patients with palmoplantar pustulosis. Br J Dermatol. 2002;146:383\u201391.","journal-title":"Br J Dermatol"},{"key":"745_CR67","first-page":"583","volume":"45","author":"GK Johnson","year":"2010","unstructured":"Johnson GK, Guthmiller JM, Joly S, et al. Interleukin-1 and interleukin-8 in nicotine- and lipopolysaccharide-exposed gingival keratinocyte cultures. J Periodontal Res. 2010;45:583\u20138.","journal-title":"J Periodontal Res"},{"key":"745_CR68","first-page":"42","volume":"62","author":"G Tsuji","year":"2011","unstructured":"Tsuji G, Takahara M, Uchi H, et al. An environmental contaminant, benzo(a)pyrene, induces oxidative stress-mediated interleukin-8 production in human keratinocytes via the aryl hydrocarbon receptor signaling pathway. J Dermatol Sci. 2011;62:42\u20139.","journal-title":"J Dermatol Sci"},{"key":"745_CR69","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature06881","volume":"453","author":"M Veldhoen","year":"2008","unstructured":"Veldhoen M, Hirota K, Westendorf AM, et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature. 2008;453:106\u20139.","journal-title":"Nature"},{"key":"745_CR70","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nature06880","volume":"453","author":"FJ Quintana","year":"2008","unstructured":"Quintana FJ, Basso AS, Iglesias AH, et al. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature. 2008;453:65\u201371.","journal-title":"Nature"},{"key":"745_CR71","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.jaci.2008.09.033","volume":"122","author":"M Yamin","year":"2008","unstructured":"Yamin M, Holbrook EH, Gray ST, et al. Cigarette smoke combined with Toll-like receptor 3 signaling triggers exaggerated epithelial regulated upon activation, normal T-cell expressed and secreted\/CCL5 expression in chronic rhinosinusitis. J Allergy Clin Immunol. 2008;122:1145\u201353.","journal-title":"J Allergy Clin Immunol"},{"key":"745_CR72","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3810\/pgm.2000.01.810","volume":"107","author":"V Fatourechi","year":"2000","unstructured":"Fatourechi V. Demystifying autoimmune thyroid disease: which disorders require treatment? Postgrad Med. 2000;107:127\u201334.","journal-title":"Postgrad Med"},{"key":"745_CR73","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1136\/ard.47.10.809","volume":"47","author":"E Edlund","year":"1988","unstructured":"Edlund E, Johnsson U, Lidgren L, et al. Palmoplantar pustulosis and sternocostoclavicular arthro-osteitis. Ann Rheum Dis. 1988;47:809\u201315.","journal-title":"Ann Rheum Dis"},{"key":"745_CR74","doi-asserted-by":"publisher","first-page":"ftw111","DOI":"10.1093\/femspd\/ftw111","volume":"74","author":"M Valeri","year":"2016","unstructured":"Valeri M, Raffatellu M. Cytokines IL-17 and IL-22 in the host response to infection. Pathog Dis. 2016;74:ftw111.","journal-title":"Pathog Dis"},{"key":"745_CR75","first-page":"488","volume":"56","author":"AA El-Zayadi","year":"2017","unstructured":"El-Zayadi AA, Jones EA, Churchman SM, et al. Interleukin-22 drives the proliferation, migration and osteogenic differentiation of mesenchymal stem cells: a novel cytokine that could contribute to new bone formation in spondyloarthropathies. Rheumatology. 2017;56:488\u201393.","journal-title":"Rheumatology"},{"key":"745_CR76","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1172\/JCI28551","volume":"116","author":"V Krishnan","year":"2006","unstructured":"Krishnan V, Bryant HU, MacDougald OA. Regulation of bone mass by Wnt signaling. J Clin Invest. 2006;116:1202\u20139.","journal-title":"J Clin Invest"},{"key":"745_CR77","doi-asserted-by":"publisher","first-page":"272","DOI":"10.7150\/ijbs.2929","volume":"8","author":"G Chen","year":"2012","unstructured":"Chen G, Deng C, Li Y-P. TGF-\u03b2 and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci. 2012;8:272\u201388.","journal-title":"Int J Biol Sci"},{"key":"745_CR78","doi-asserted-by":"crossref","first-page":"540","DOI":"10.2340\/0001555571540542","volume":"71","author":"K Kragballe","year":"1991","unstructured":"Kragballe K, Larsen FG. A hydrocolloid occlusive dressing plus triamcinolone acetonide cream is superior to Clobetasol cream in palmo-plantar pustulosis. Acta Derm Venereol. 1991;71:540\u20132.","journal-title":"Acta Derm Venereol"},{"key":"745_CR79","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/ijd.12790","volume":"54","author":"T Soleymani","year":"2015","unstructured":"Soleymani T, Hung T, Soung J. The role of vitamin D in psoriasis: a review. Int J Dermatol. 2015;54:383\u201392.","journal-title":"Int J Dermatol"},{"key":"745_CR80","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1111\/j.1365-2133.2010.09692.x","volume":"162","author":"KI Yamanaka","year":"2010","unstructured":"Yamanaka KI, Kakeda M, Kitagawa H, Tsuda K, Akeda T, Kurokawa I, Gabazza EC, Kupper TS, Mizutani H. 1,24-Dihydroxyvitamin D3 (tacalcitol) prevents skin T-cell infiltration. Br J Dermatol. 2010;162:1206\u201315.","journal-title":"Br J Dermatol"},{"key":"745_CR81","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/1346-8138.13064","volume":"43","author":"Y Umezawa","year":"2016","unstructured":"Umezawa Y, Nakagawa H, Tamaki K. Phase III clinical study of maxacalcitol ointment in patients with palmoplantar pustulosis: a randomized, double-blind, placebo-controlled trial. J Dermatol. 2016;43:288\u201393.","journal-title":"J Dermatol"},{"key":"745_CR82","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3109\/09546634.2015.1052036","volume":"27","author":"M Muro","year":"2016","unstructured":"Muro M, Kawakami H, Matsumoto Y, et al. Topical combination therapy with vitamin D3 and corticosteroid ointment for palmoplantar pustulosis: a prospective, randomized, left-right comparison study. J Dermatolog Treat. 2016;27:51\u20133.","journal-title":"J Dermatolog Treat"},{"key":"745_CR83","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1540-9740.2007.06485.x","volume":"7","author":"VN Sehgal","year":"2008","unstructured":"Sehgal VN, Srivastava G, Dogra S. Tacrolimus in dermatology-pharmacokinetics, mechanism of action, drug interaction, dosages, and side effects: part I. Skinmed. 2008;7:27\u201330.","journal-title":"Skinmed"},{"key":"745_CR84","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1111\/j.1365-2133.2005.06779.x","volume":"153","author":"CC Lan","year":"2005","unstructured":"Lan CC, Yu HS, Wu CS, et al. FK506 inhibits tumor necrosis factor-alpha secretion in human keratinocytes via regulation of nuclear factor-kappaB. Br J Dermatol. 2005;153:725\u201332.","journal-title":"Br J Dermatol"},{"key":"745_CR85","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1001\/archdermatol.2011.120","volume":"147","author":"L Laino","year":"2011","unstructured":"Laino L, DiCarlo A. Palmoplantar pustular psoriasis: clinical and video thermographic evaluation before and after topical tacrolimus treatment. Arch Dermatol. 2011;147:760.","journal-title":"Arch Dermatol"},{"key":"745_CR86","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/j.1600-0625.2011.01316.x","volume":"20","author":"T Furuhashi","year":"2011","unstructured":"Furuhashi T, Torii K, Kato H, et al. Efficacy of excimer light therapy (308\u00a0nm) for palmoplantar pustulosis with the induction of circulating regulatory T cells. Exp Dermatol. 2011;20:768\u201370.","journal-title":"Exp Dermatol"},{"key":"745_CR87","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/1346-8138.12228","volume":"40","author":"A Kawada","year":"2013","unstructured":"Kawada A, Matsuda H, Oiso N. Efficacy and safety of targeted narrowband ultraviolet B therapy using a flat-type fluorescent lamp for the treatment of palmoplantar pustulosis. J Dermatol. 2013;40:754\u20135.","journal-title":"J Dermatol"},{"key":"745_CR88","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1111\/1346-8138.12302","volume":"40","author":"T Fumimori","year":"2013","unstructured":"Fumimori T, Tsuruta D, Kawakami T, et al. Effect of monochromatic excimer light on palmoplantar pustulosis: a clinical study performed in a private clinic by a dermatological specialist. J Dermatol. 2013;40:1004\u20137.","journal-title":"J Dermatol"},{"key":"745_CR89","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1007\/s10103-017-2280-0","volume":"32","author":"LN Su","year":"2017","unstructured":"Su LN, Ren J, Cheng SM, et al. UVA vs. narrowband UVB phototherapy in the treatment of palmoplantar pustulosis: a pilot randomized controlled study. Lasers Med Sci. 2017;32:1819\u201323.","journal-title":"Lasers Med Sci"},{"key":"745_CR90","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.4049\/jimmunol.1303245","volume":"192","author":"M Raverdeau","year":"2014","unstructured":"Raverdeau M, Mills KHG. Modulation of T cell and innate immune responses by retinoic acid. J Immunol. 2014;192:2953\u20138.","journal-title":"J Immunol"},{"key":"745_CR91","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/j.1365-2133.2012.11063.x","volume":"167","author":"N Irla","year":"2012","unstructured":"Irla N, Navarini AA, Yawalkar N. Alitretinoin abrogates innate inflammation in palmoplantar pustular psoriasis. Br J Dermatol. 2012;167:1170\u20134.","journal-title":"Br J Dermatol"},{"key":"745_CR92","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1111\/bjd.14401","volume":"174","author":"K Reich","year":"2016","unstructured":"Reich K, Graff O, Mehta N. Oral alitretinoin treatment in patients with palmoplantar pustulosis inadequately responding to standard topical treatment: a randomized phase II study. Br J Dermatol. 2016;174:1277\u201381.","journal-title":"Br J Dermatol"},{"key":"745_CR93","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5070\/D3218028439","volume":"21","author":"R Wilken","year":"2015","unstructured":"Wilken R, Sharma A, Patel F, Maverakis E. Successful treatment of palmoplantar pustulosis with isotretinoin. Dermatol Online J. 2015;21:14.","journal-title":"Dermatol Online J"},{"key":"745_CR94","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1684\/ejd.2009.0727","volume":"19","author":"S-J Shan","year":"2009","unstructured":"Shan S-J, Li Y-H, Zhang G, et al. Treatment of palmoplantar pustulosis with arotinoid ethylester. Eur J Dermatol. 2009;19:474\u20137.","journal-title":"Eur J Dermatol"},{"key":"745_CR95","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1046\/j.1365-2133.1998.02555.x","volume":"139","author":"P Erkko","year":"1998","unstructured":"Erkko P, Granlund H, Remitz A, et al. Double-blind placebo-controlled study of long-term low-dose cyclosporin in the treatment of palmoplantar pustulosis. Br J Dermatol. 1998;139:997\u20131004.","journal-title":"Br J Dermatol"},{"key":"745_CR96","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/j.1346-8138.2004.tb00579.x","volume":"31","author":"T Yamamoto","year":"2004","unstructured":"Yamamoto T, Nishioka K. Severe extra-palmoplantar pustulation associated with palmoplantar pustulosis. J Dermatol. 2004;31:690\u20132.","journal-title":"J Dermatol"},{"key":"745_CR97","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/j.1346-8138.1995.tb03435.x","volume":"22","author":"T Yamamoto","year":"1995","unstructured":"Yamamoto T, Kimura K, Katayama I, Nishioka K. Successful treatment of severe arthralgia associated with palmoplantar pustulosis with low-dose oral cycloporine A. J Dermatol. 1995;22:512\u20134.","journal-title":"J Dermatol"},{"key":"745_CR98","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1046\/j.1365-2230.2001.00759.x","volume":"26","author":"M Vaccaro","year":"2001","unstructured":"Vaccaro M, Borgia F, Guarneri F, et al. Successful treatment of pustulotic arthro-osteitis (Sonozaki syndrome) with systemic cyclosporin. Clin Exp Dermatol. 2001;26:45\u20137.","journal-title":"Clin Exp Dermatol"},{"key":"745_CR99","first-page":"758","volume":"20","author":"K Hayama","year":"2010","unstructured":"Hayama K, Inadomi T, Fujisawa D, Terui T. A pilot study of medium-dose cyclosporine for the treatment of palmoplantar pustulosis complicated with pustulotic arthro-osteitis. Eur J Dermatol. 2010;20:758\u201362.","journal-title":"Eur J Dermatol"},{"key":"745_CR100","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1111\/j.1365-2133.2011.10233.x","volume":"164","author":"U Mrowietz","year":"2011","unstructured":"Mrowietz U, van de Kerkhof PCM. Management of palmoplantar pustulosis: do we need to change? Br J Dermatol. 2011;164:942\u20136.","journal-title":"Br J Dermatol"},{"key":"745_CR101","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1111\/j.1468-3083.2009.03197.x","volume":"23","author":"E Adisen","year":"2009","unstructured":"Adisen E, Tekin O, G\u00fclekon A, G\u00fcrer MA. A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patients. J Eur Acad Dermatol Venereol. 2009;23:814\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"745_CR102","first-page":"153","volume":"94","author":"CW Stanford","year":"2014","unstructured":"Stanford CW, Kollipara R, Melookaran AM, Hall JC. Palmoplantar pustular psoriasis following initiation of a beta-blocker: disease control with low-dose methotrexate. Cutis. 2014;94:153\u20135.","journal-title":"Cutis"},{"key":"745_CR103","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1365-2133.1973.tb02977.x","volume":"89","author":"K Thomsen","year":"1973","unstructured":"Thomsen K, Osterbye P. Pustulosis palmaris et plantaris. Br J Dermatol. 1973;89:293\u20136.","journal-title":"Br J Dermatol"},{"key":"745_CR104","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/1523-1747.ep12285793","volume":"86","author":"Y Miyachi","year":"1986","unstructured":"Miyachi Y, Yoshioka A, Imamura S, Niwa Y. Effect of antibiotics on the generation of reactive oxygen species. J Invest Dermatol. 1986;86:449\u201353.","journal-title":"J Invest Dermatol"},{"key":"745_CR105","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1159\/000439401","volume":"231","author":"M Murakami","year":"2015","unstructured":"Murakami M, Masuda K, Utsunomiya R, et al. Cefcapene pivoxil hydrochloride is a potentially new treatment for palmoplantar pustulosis with pustulotic arthro-osteitis. Dermatology. 2015;231:304\u201311.","journal-title":"Dermatology"},{"key":"745_CR106","doi-asserted-by":"publisher","first-page":"659","DOI":"10.2174\/1381612824666180123110042","volume":"24","author":"C Angelidis","year":"2018","unstructured":"Angelidis C, Kotsialou Z, Kossyvakis C, et al. Colchicine pharmacokinetics and mechanism of action. Curr Pharm Des. 2018;24:659\u201363.","journal-title":"Curr Pharm Des"},{"key":"745_CR107","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1001\/archderm.1982.01650190012009","volume":"118","author":"M Takigawa","year":"1982","unstructured":"Takigawa M, Miyachi Y, Uehara M, Tagami H. Treatment of pustulosis palmaris et plantaris with oral doses of colchicine. Arch Dermatol. 1982;118:458\u201360.","journal-title":"Arch Dermatol"},{"key":"745_CR108","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2340\/00015555647678","volume":"64","author":"K Thestrup-Pedersen","year":"1984","unstructured":"Thestrup-Pedersen K, Reymann F. Treatment of pustulosis palmaris et plantaris with colchicine. Acta Derm Venereol. 1984;64:76\u20138.","journal-title":"Acta Derm Venereol"},{"key":"745_CR109","first-page":"216","volume":"68","author":"SS Wong","year":"2001","unstructured":"Wong SS, Tan KC, Goh CL. Long-term colchicine for recalcitrant palmoplantar pustulosis: treatment outcome in 3 patients. Cutis. 2001;68:216\u20138.","journal-title":"Cutis"},{"key":"745_CR110","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/ijd.13608","volume":"56","author":"S Hayashi","year":"2017","unstructured":"Hayashi S, Shimaoka Y, Hamasaki Y, Hatamochi A. Palmoplantar pustulosis and pustulotic arthro-osteitis treatment with potassium iodide and tetracycline, a novel remedy with an old drug: a review of 25 patients. Int J Dermatol. 2017;56:889\u201393.","journal-title":"Int J Dermatol"},{"key":"745_CR111","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1001\/archderm.134.5.639","volume":"134","author":"M Mihara","year":"1998","unstructured":"Mihara M, Hagari Y, Morimura T, et al. Itraconazole as a new treatment for pustulosis palmaris et plantaris. Arch Dermatol. 1998;134:639\u201340.","journal-title":"Arch Dermatol"},{"key":"745_CR112","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1529-8019.2008.01219.x","volume":"22","author":"MT V\u2019lckova-Laskoska","year":"2009","unstructured":"V\u2019lckova-Laskoska MT, Caca-Biljanovska NG, Laskoski DS, Kamberova SJ. Palmoplantar pustulosis treated with itraconazole: a single, active-arm pilot study. Dermatol Ther. 2009;22:85\u20139.","journal-title":"Dermatol Ther"},{"key":"745_CR113","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1111\/ddg.12825","volume":"14","author":"V Buder","year":"2016","unstructured":"Buder V, Herberger K, Jacobi A, et al. Ustekinumab in the treatment of palmoplantar pustular psoriasis: a case series of nine patients. J Dtsch Dermatol Ges. 2016;14:1108\u201313.","journal-title":"J Dtsch Dermatol Ges"},{"key":"745_CR114","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/bjd.12150","volume":"168","author":"C Morales-M\u00fanera","year":"2013","unstructured":"Morales-M\u00fanera C, Vilarrasa E, Puig L. Efficacy of ustekinumab in refractory palmoplantar pustular psoriasis. Br J Dermatol. 2013;168:820\u20134.","journal-title":"Br J Dermatol"},{"key":"745_CR115","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/j.1365-2133.2010.09897.x","volume":"163","author":"S Gerdes","year":"2010","unstructured":"Gerdes S, Franke J, Domm S, Mrowietz U. Ustekinumab in the treatment of palmoplantar pustulosis. Br J Dermatol. 2010;163:1116\u20138.","journal-title":"Br J Dermatol"},{"key":"745_CR116","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.ad.2011.03.026","volume":"102","author":"B Unamuno-Bustos De","year":"2011","unstructured":"De Unamuno-Bustos B, Ballester-S\u00e1nchez R, Oliver-Martinez V, de Miquel AV. Ustekinumab for the treatment of palmar-plantar pustulosis. Actas Dermosifiliogr. 2011;102:833\u20135.","journal-title":"Actas Dermosifiliogr"},{"key":"745_CR117","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/1346-8138.13447","volume":"44","author":"T Ohashi","year":"2017","unstructured":"Ohashi T, Suzuki Y, Yamamoto T. Use of biologics for pustulotic arthro-osteitis in two patients with palmoplantar pustulosis. J Dermatol. 2017;44:97\u20138.","journal-title":"J Dermatol"},{"key":"745_CR118","doi-asserted-by":"publisher","first-page":"e204","DOI":"10.1111\/jdv.14718","volume":"32","author":"S Hegazy","year":"2018","unstructured":"Hegazy S, Konstantinou MP, Bulai Livideanu C, et al. Efficacy of ustekinumab in palmoplantar pustulosis. J Eur Acad Dermatol Venereol. 2018;32:e204\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"745_CR119","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1001\/jamadermatol.2017.5937","volume":"154","author":"T Terui","year":"2018","unstructured":"Terui T, Kobayashi S, Okubo Y, et al. Efficacy and safety of guselkumab, an anti-interleukin 23 monoclonal antibody, for palmoplantar pustulosis: a randomized clinical trial. JAMA Dermatol. 2018;154:309\u201316.","journal-title":"JAMA Dermatol"},{"key":"745_CR120","doi-asserted-by":"publisher","first-page":"202","DOI":"10.2310\/7750.2007.00036","volume":"11","author":"LC Guenther","year":"2007","unstructured":"Guenther LC. Alefacept is safe and efficacious in the treatment of palmoplantar pustulosis. J Cutan Med Surg. 2007;11:202\u20135.","journal-title":"J Cutan Med Surg"},{"key":"745_CR121","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/09546630701364776","volume":"19","author":"D Carr","year":"2008","unstructured":"Carr D, Tusa MG, Carroll CL, et al. Open label trial of alefacept in palmoplantar pustular psoriasis. J Dermatol Treat. 2008;19:97\u2013100.","journal-title":"J Dermatol Treat"},{"key":"745_CR122","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.1016\/j.jaad.2011.05.038","volume":"67","author":"E Shmidt","year":"2012","unstructured":"Shmidt E, Wetter DA, Ferguson SB, Pittelkow MR. Psoriasis and palmoplantar pustulosis associated with tumor necrosis factor-\u03b1 inhibitors: the Mayo Clinic experience, 1998 to 2010. J Am Acad Dermatol. 2012;67:e179\u201385.","journal-title":"J Am Acad Dermatol"},{"key":"745_CR123","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jdcr.2017.03.002","volume":"3","author":"KM Torre","year":"2017","unstructured":"Torre KM, Payette MJ. Combination biologic therapy for the treatment of severe palmoplantar pustulosis. JAAD Case Rep. 2017;3:240\u20132.","journal-title":"JAAD Case Rep"},{"key":"745_CR124","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/1744-9987.12210","volume":"18","author":"T Fujisawa","year":"2014","unstructured":"Fujisawa T, Tawada C, Mizutani Y, et al. Efficacy of granulocyte and monocyte adsorption apheresis for treatment of palmoplantar pustulosis. Ther Apher Dial. 2014;18:238\u201343.","journal-title":"Ther Apher Dial"},{"key":"745_CR125","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/1744-9987.12113","volume":"17","author":"M Sakanoue","year":"2013","unstructured":"Sakanoue M, Takeda K, Kawai K, Kanekura T. Granulocyte and monocyte adsorption apheresis for refractory skin diseases due to activated neutrophils, psoriasis and associated arthropathy. Ther Apher Dial. 2013;17:477\u201383.","journal-title":"Ther Apher Dial"},{"key":"745_CR126","doi-asserted-by":"publisher","first-page":"e167","DOI":"10.1111\/1346-8138.14191","volume":"45","author":"A Arimura","year":"2018","unstructured":"Arimura A, Fujii K, Ibusuki A, et al. Granulocyte and monocyte adsorption apheresis for palmoplantar pustulosis with extra-palmoplantar lesions and pustulotic arthro-osteitis. J Dermatol. 2018;45:e167\u20138.","journal-title":"J Dermatol"},{"key":"745_CR127","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1023\/A:1015330816364","volume":"47","author":"N Kashiwagi","year":"2002","unstructured":"Kashiwagi N, Sugimura K, Koiwai H, et al. Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis. Dig Dis Sci. 2002;47:1334\u201341.","journal-title":"Dig Dis Sci"},{"key":"745_CR128","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3109\/00016488309121152","volume":"401","author":"T Ono","year":"1983","unstructured":"Ono T, Jono M, Kito M, et al. Evaluation of tonsillectomy as a treatment for pustulosis palmaris et plantaris. Acta Otolaryngol Suppl. 1983;401:12\u20136.","journal-title":"Acta Otolaryngol Suppl"},{"key":"745_CR129","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1080\/00016480410018124","volume":"124","author":"M Yokoyama","year":"2004","unstructured":"Yokoyama M, Hashiguchi K, Yamasaki Y. Effect of tonsillectomy in patients with pustulosis palmaris et plantaris. Acta Otolaryngol. 2004;124:1109\u201310.","journal-title":"Acta Otolaryngol"},{"key":"745_CR130","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/1346-8138.14348","volume":"45","author":"M Takahara","year":"2018","unstructured":"Takahara M, Hirata Y, Nagato T, et al. Treatment outcome and prognostic factors of tonsillectomy for palmoplantar pustulosis and pustulotic arthro-osteitis: a retrospective sunjective and objective quantitative analysis of 138 patients. J Dermatol. 2018;45:812\u201323.","journal-title":"J Dermatol"},{"key":"745_CR131","first-page":"89","volume":"72","author":"T Yamamoto","year":"2011","unstructured":"Yamamoto T. Triggering role of focal infection in the induction of extra-palmoplantar lesions and pustulotic arthro-osteitis associated with palmoplantar pustulosis. Adv Otorhinolaryngol. 2011;72:89\u201392.","journal-title":"Adv Otorhinolaryngol"},{"key":"745_CR132","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/000155598441431","volume":"78","author":"T Yamamoto","year":"1998","unstructured":"Yamamoto T, Katayama I, Nishioka K. Restricted usage of the T-cell receptor V\u03b2 repertoire in tonsillitis in association with palmoplantar pustulosis. Acta Derm Venereol (Stockh). 1998;78:161\u20133.","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"745_CR133","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1111\/jdv.14187","volume":"31","author":"H Trattner","year":"2017","unstructured":"Trattner H, Bl\u00fcml S, Steiner I, et al. Quality of life and comorbidities in palmoplantar pustulosis: a cross-sectional study on 102 patients. J Eur Acad Dermatol Venereol. 2017;31:1681\u20135.","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-018-00745-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-018-00745-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-018-00745-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T16:45:14Z","timestamp":1694537114000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-018-00745-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,10]]},"references-count":133,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["745"],"URL":"https:\/\/doi.org\/10.1007\/s40261-018-00745-6","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,10]]},"assertion":[{"value":"10 January 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Toshiyuki Yamamoto has no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No funding sources were used to assist in the preparation of this review.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}}]}}